17 ALPHA-HYDROXY-4-ANDROSTENE-3-ONE AND THE 14, 15-METHYLENE-DERIVATIVES THEREOF

Details for Australian Patent Application No. 2001260300 (hide)

Owner JENAPHARM GMBH AND CO. KG

Inventors ROMER, Wolfgang; SCHREIBER, Gerhard; OETTEL, Michael; BERLAU, Jens

Pub. Number AU-A-2001260300

PCT Pub. Number WO2002/092618

Filing date 15 May 2001

Wipo publication date 25 November 2002

International Classifications

C07J 001/00 Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing carbon, hydrogen, halogen, or oxygen

C07J 053/00 Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by condensation with carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms

A61K 031/565 - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61P 005/26 Drugs for disorders of the endocrine system

A61P 015/16 Drugs for genital or sexual disorders

Event Publications

1 May 2003 Application Open to Public Inspection

  Published as AU-A-2001260300

4 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001260301-Novel phenyl-propargylether derivatives

2001260299